{"transactions":[{"id":2655184,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":137911,"kind":"person","name":"Fishel Robert Scott","position":1,"cik":"0001735476","reported_name":"Fishel Robert Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-25T12:43:50.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":3.77,"exercise_date":"2022-06-24","expiration_date":"2031-06-23","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-21-043211","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919121043211/doc4.xml","form_type":"4"}},{"id":2896239,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":137911,"kind":"person","name":"Fishel Robert Scott","position":1,"cik":"0001735476","reported_name":"Fishel Robert Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-26T21:07:11.000Z","date":"2021-01-25","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.03,"exercise_date":"2020-06-20","expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-005357","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919121005357/doc4.xml","form_type":"4"}},{"id":2896238,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":137911,"kind":"person","name":"Fishel Robert Scott","position":1,"cik":"0001735476","reported_name":"Fishel Robert Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-26T21:07:11.000Z","date":"2021-01-25","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":3.04,"exercise_date":"2019-04-03","expiration_date":"2028-04-02","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-21-005357","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919121005357/doc4.xml","form_type":"4"}},{"id":2896237,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":137911,"kind":"person","name":"Fishel Robert Scott","position":1,"cik":"0001735476","reported_name":"Fishel Robert Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-26T21:07:11.000Z","date":"2021-01-25","kind":"exercise","acquired":true,"shares":20000,"price":2.03,"value":40600.0,"ownership":{"direct":true},"balance_after":60000,"source":{"system":"sec-edgar","filing":"0001209191-21-005357","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919121005357/doc4.xml","form_type":"4"}},{"id":2896236,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":137911,"kind":"person","name":"Fishel Robert Scott","position":1,"cik":"0001735476","reported_name":"Fishel Robert Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-26T21:07:11.000Z","date":"2021-01-25","kind":"exercise","acquired":true,"shares":40000,"price":3.04,"value":121600.0,"ownership":{"direct":true},"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001209191-21-005357","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919121005357/doc4.xml","form_type":"4"}},{"id":3099324,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":137911,"kind":"person","name":"Fishel Robert Scott","position":1,"cik":"0001735476","reported_name":"Fishel Robert Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-26T12:46:05.000Z","date":"2020-06-25","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20000,"derivative":{"exercise_price":2.68,"exercise_date":"2021-06-25","expiration_date":"2030-06-24","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-039037","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919120039037/doc4.xml","form_type":"4"}},{"id":3481751,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":137911,"kind":"person","name":"Fishel Robert Scott","position":1,"cik":"0001735476","reported_name":"Fishel Robert Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-21T10:38:16.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20000,"derivative":{"exercise_price":2.03,"exercise_date":"2020-06-20","expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-19-038351","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919119038351/doc4.xml","form_type":"4"}},{"id":3509276,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":137911,"kind":"person","name":"Fishel Robert Scott","position":1,"cik":"0001735476","reported_name":"Fishel Robert Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-29T10:10:34.000Z","date":"2019-05-28","kind":"purchase","acquired":true,"shares":50000,"price":1.92,"value":96000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO.  The general partner of ALSAR Ltd. Partnership is SARAL Corporation.  Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation."}],"balance_after":4120728,"source":{"system":"sec-edgar","filing":"0001209191-19-033120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919119033120/doc4.xml","form_type":"4"}},{"id":3821274,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":137911,"kind":"person","name":"Fishel Robert Scott","position":1,"cik":"0001735476","reported_name":"Fishel Robert Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-10T10:30:17.000Z","date":"2018-09-07","kind":"purchase","acquired":true,"shares":10000,"price":4.63,"value":46300.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO.  The general partner of ALSAR Ltd. Partnership is SARAL Corporation.  Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation."}],"balance_after":4070728,"source":{"system":"sec-edgar","filing":"0001209191-18-050181","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919118050181/doc4.xml","form_type":"4"}},{"id":3868915,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":137911,"kind":"person","name":"Fishel Robert Scott","position":1,"cik":"0001735476","reported_name":"Fishel Robert Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-12T11:12:15.000Z","date":"2018-07-11","kind":"purchase","acquired":true,"shares":2500,"price":5.9965,"value":14991.25,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO.  The general partner of ALSAR Ltd. Partnership is SARAL Corporation.  Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation."}],"balance_after":4060728,"source":{"system":"sec-edgar","filing":"0001209191-18-042414","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919118042414/doc4.xml","form_type":"4"}},{"id":3885437,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":137911,"kind":"person","name":"Fishel Robert Scott","position":1,"cik":"0001735476","reported_name":"Fishel Robert Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-22T20:14:13.000Z","date":"2018-06-21","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20000,"derivative":{"exercise_price":4.46,"exercise_date":"2019-06-21","expiration_date":"2028-06-20","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-18-039174","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919118039174/doc4.xml","form_type":"4"}},{"id":3914523,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":137911,"kind":"person","name":"Fishel Robert Scott","position":1,"cik":"0001735476","reported_name":"Fishel Robert Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-30T11:29:06.000Z","date":"2018-05-29","kind":"purchase","acquired":true,"shares":2500,"price":3.733,"value":9332.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO.  The general partner of ALSAR Ltd. Partnership is SARAL Corporation.  Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation."}],"balance_after":4058228,"source":{"system":"sec-edgar","filing":"0001209191-18-034061","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919118034061/doc4.xml","form_type":"4"}},{"id":3933559,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":137911,"kind":"person","name":"Fishel Robert Scott","position":1,"cik":"0001735476","reported_name":"Fishel Robert Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-15T10:04:15.000Z","date":"2018-05-14","kind":"purchase","acquired":true,"shares":1800,"price":4.79,"value":8622.0,"ownership":{"direct":false,"nature":"ALSAR Ltd. Partnership"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO.  The general partner of ALSAR Ltd. Partnership is SARAL Corporation.  Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation."}],"balance_after":4055728,"source":{"system":"sec-edgar","filing":"0001209191-18-030093","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919118030093/doc4.xml","form_type":"4"}},{"id":3944711,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":137911,"kind":"person","name":"Fishel Robert Scott","position":1,"cik":"0001735476","reported_name":"Fishel Robert Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-07T10:57:05.000Z","date":"2018-05-04","kind":"purchase","acquired":true,"shares":5000,"price":3.14,"value":15700.0,"ownership":{"direct":false,"nature":"See Footnote"},"balance_after":4053928,"source":{"system":"sec-edgar","filing":"0001209191-18-028209","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919118028209/doc4.xml","form_type":"4"}},{"id":3956455,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":137911,"kind":"person","name":"Fishel Robert Scott","position":1,"cik":"0001735476","reported_name":"Fishel Robert Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-26T10:24:02.000Z","date":"2018-04-25","kind":"purchase","acquired":true,"shares":2500,"price":3.03,"value":7575.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO.  The general partner of ALSAR Ltd. Partnership is SARAL Corporation.  Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation."}],"balance_after":4048928,"source":{"system":"sec-edgar","filing":"0001209191-18-026150","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919118026150/doc4.xml","form_type":"4"}},{"id":3956454,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":137911,"kind":"person","name":"Fishel Robert Scott","position":1,"cik":"0001735476","reported_name":"Fishel Robert Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-26T10:24:02.000Z","date":"2018-04-25","kind":"purchase","acquired":true,"shares":5000,"price":2.97,"value":14850.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO.  The general partner of ALSAR Ltd. Partnership is SARAL Corporation.  Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation."}],"balance_after":4046428,"source":{"system":"sec-edgar","filing":"0001209191-18-026150","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919118026150/doc4.xml","form_type":"4"}},{"id":3956453,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":137911,"kind":"person","name":"Fishel Robert Scott","position":1,"cik":"0001735476","reported_name":"Fishel Robert Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-26T10:24:02.000Z","date":"2018-04-25","kind":"purchase","acquired":true,"shares":5000,"price":2.94,"value":14700.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO.  The general partner of ALSAR Ltd. Partnership is SARAL Corporation.  Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation."}],"balance_after":4041428,"source":{"system":"sec-edgar","filing":"0001209191-18-026150","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919118026150/doc4.xml","form_type":"4"}},{"id":3962560,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":137911,"kind":"person","name":"Fishel Robert Scott","position":1,"cik":"0001735476","reported_name":"Fishel Robert Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-17T10:52:06.000Z","date":"2018-04-16","kind":"purchase","acquired":true,"shares":10000,"price":3.01,"value":30100.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO.  The general partner of ALSAR Ltd. Partnership is SARAL Corporation.  Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation."}],"balance_after":4036428,"source":{"system":"sec-edgar","filing":"0001209191-18-025059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919118025059/doc4.xml","form_type":"4"}},{"id":3962559,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":137911,"kind":"person","name":"Fishel Robert Scott","position":1,"cik":"0001735476","reported_name":"Fishel Robert Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-17T10:52:06.000Z","date":"2018-04-16","kind":"purchase","acquired":true,"shares":5000,"price":3,"value":15000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO.  The general partner of ALSAR Ltd. Partnership is SARAL Corporation.  Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation."}],"balance_after":4026428,"source":{"system":"sec-edgar","filing":"0001209191-18-025059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919118025059/doc4.xml","form_type":"4"}},{"id":3963469,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":137911,"kind":"person","name":"Fishel Robert Scott","position":1,"cik":"0001735476","reported_name":"Fishel Robert Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-16T10:48:52.000Z","date":"2018-04-13","kind":"purchase","acquired":true,"shares":10000,"price":3.02,"value":30200.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO.  The general partner of ALSAR Ltd. Partnership is SARAL Corporation.  Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation."}],"balance_after":4021428,"source":{"system":"sec-edgar","filing":"0001209191-18-024884","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919118024884/doc4.xml","form_type":"4"}},{"id":3967178,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":137911,"kind":"person","name":"Fishel Robert Scott","position":1,"cik":"0001735476","reported_name":"Fishel Robert Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-09T10:07:08.000Z","date":"2018-04-06","kind":"purchase","acquired":true,"shares":10000,"price":3.16,"value":31600.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO.  The general partner of ALSAR Ltd. Partnership is SARAL Corporation.  Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation."}],"balance_after":4011428,"source":{"system":"sec-edgar","filing":"0001209191-18-024269","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919118024269/doc4.xml","form_type":"4"}},{"id":3970625,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":137911,"kind":"person","name":"Fishel Robert Scott","position":1,"cik":"0001735476","reported_name":"Fishel Robert Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-04T20:13:05.000Z","date":"2018-04-03","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40000,"derivative":{"exercise_price":3.04,"exercise_date":"2019-04-03","expiration_date":"2028-04-02","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-18-023608","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919118023608/doc4.xml","form_type":"4"}}]}